Despite significant advances in medicine, an effective vaccine for the human immunodeficiency virus (HIV) is still not available, although recent hope has emerged through the discovery of antibodies capable of neutralizing diverse HIV strains. However, HIV can sometimes evade known broadly neutralizing antibody responses via mutational pathways, which makes it all the more difficult to design an effective solution.